The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 06, 2018
Filed:
Oct. 03, 2016
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Tinya Abrams, Acton, MA (US);
Steven Bruce Cohen, San Diego, CA (US);
Christie P. Fanton, Oakland, CA (US);
Thomas Huber, Basel, CH;
Kathy Miller, San Francisco, CA (US);
Siew Ho Schleyer, El Cerrito, CA (US);
Kathrin Ulrike Tissot-Daguette, Neuried, DE;
Catrin Finner, Taxetweg, DE;
Assignee:
Novartis AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); A61K 47/68 (2017.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01); A61K 31/537 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 9/19 (2006.01); A61K 9/00 (2006.01); A61K 49/00 (2006.01); A61K 51/10 (2006.01); C07K 16/32 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6803 (2017.08); A61K 9/0019 (2013.01); A61K 9/19 (2013.01); A61K 31/537 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/6801 (2017.08); A61K 47/6849 (2017.08); A61K 47/6855 (2017.08); A61K 47/6857 (2017.08); A61K 47/6865 (2017.08); A61K 47/6867 (2017.08); A61K 47/6889 (2017.08); A61K 49/00 (2013.01); A61K 51/103 (2013.01); A61K 51/1093 (2013.01); C07K 16/2803 (2013.01); C07K 16/2863 (2013.01); C07K 16/32 (2013.01); A61K 2039/505 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/30 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.